The US Food and Drug Administration has classified a drug developed in Mallorca as an orphan drug, this being a drug that is not developed by the pharmaceutical industry for economic reasons but as a response to a public health need. It is typically the case that because a medical condition is rare, it would not be profitable to produce the drug without government assistance.
No comments
To be able to write a comment, you have to be registered and logged in
Currently there are no comments.